Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Xenetic Biosciences (XBIO) Other Operating Expenses (2025)

Xenetic Biosciences' Other Operating Expenses history spans 5 years, with the latest figure at $273416.0 for Q4 2025.

  • For Q4 2025, Other Operating Expenses changed N/A year-over-year to $273416.0; the TTM value through Dec 2025 reached $273416.0, changed N/A, while the annual FY2013 figure was $10668.0, 94.48% down from the prior year.
  • Other Operating Expenses reached $273416.0 in Q4 2025 per XBIO's latest filing, up from -$1.1 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $273416.0 in Q4 2025 to a low of $273416.0 in Q4 2025.